The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments

Overview of attention for article published in Frontiers in immunology, May 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 2 news outlets
twitter: 9 X users

patent: 1 patent

Citations

dimensions_citation: 157 Dimensions

Readers on

mendeley: 271 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

NK Cell–Targeting Strategies Come Into Their Own

OncLive, 16 Apr 2021

Although anticancer therapies that leverage T cells have commanded the most attention in the immuno-oncology era of the past…

Natural killer cells may be scaled and engineered as a next generation, off-the-shelf cell therapy for cancer

BioInsights, 04 Jul 2019

Advantages

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.